of those. so waiving the intellectual property rights is not going to be the solution, is it, in the short term? it s not going to be the solution in the short term, but it s the beginning of, at least, a short term to a long term solution that we need to embark on that journey. look, countries like india, china, thailand started somewhere, and the somewhere was that it took them at least 15 years to 20 years to be able to produce vaccines as care, and that is where we find ourselves as a continent. as we speak, there are several sites on the continent that have the capacity and capabilities of producing vaccines like the pasteur institute in senegal. south africa, egypt, morocco and tunisia, they all have that capacity and know how to produce, but they need to be supported, both in terms of technology transfer, both in terms of ip waiver, and in terms of really appropriate partnerships to enable them to move quickly into the areas of vaccine manufacturing there. so we are notjust a co
going to be the solution, is it, in the short term? it s not going to be the solution in the short term, but it s the beginning of, at least, a short term to a long term solution that we need to embark on that journey. look, countries like india, china, thailand started somewhere, and the somewhere was that it took them at least 15 years to 20 years to be able to produce vaccines at scale, and that is where we find ourselves as a continent. as we speak, there are several sites on the continent that have the capacity and capabilities of producing vaccines, like the pasteur institute in senegal. south africa, egypt, morocco and tunisia, they all have that capacity and know how to produce, but they need to be supported, both in terms of technology transfer, both in terms of ip waiver, and in terms of really appropriate partnerships to enable them to move quickly into the areas of vaccine manufacturing there. so we are notjust a continent
so waiving the intellectual property rights is not going to be the solution, is it, in the short term? it s not going to be the solution in the short term, but it s the beginning of, at least, a short term to a long term solution that we need to embark on that journey. look, countries like india, china, thailand, started somewhere, and the somewhere was that it took them at least 15 years to 20 years to be able to produce vaccines at scale, and that is where we find ourselves as a continent. as we speak, there are several sites on the continent that have the capacity and capabilities of producing vaccines, like the pasteur institute in senegal. south africa, egypt, morocco and tunisia, they all have that capacity and know how to produce, but they need to be supported, both in terms of technology transfer, both in terms of ip waiver, and in terms of really appropriate partnerships to enable them to move quickly into the areas of vaccine
is it, in the short term? it s not going to be the solution in the short term, but it s the beginning of, at least, a short term to a long term solution that we need to embark on that journey. look, countries like india, china, thailand started somewhere, and the somewhere was that it took them at least 15 years to 20 years to be able to produce vaccines as care, and that is where we find ourselves as a continent. as we speak, there are several sites on the continent that have the capacity and capabilities of producing vaccines like the pasteur institute in senegal. south africa, egypt, morocco and tunisia, they all have that capacity and know how to produce, but they need to be supported, both in terms of technology transfer, both in terms of ip waiver, and in terms of really appropriate partnerships to enable them to move quickly into the areas of vaccine manufacturing there. so we are notjust a continent that we do not have anything,
property rights is not going to be the solution, is it, in the short term? it s not going to be the solution in the short term, but it s the beginning of, at least, a short term to a long term solution that we need to embark on that journey. look, countries like india, china, thailand started somewhere, and the somewhere was that it took them at least 15 years to 20 years to be able to produce vaccines as care, and that is where we find ourselves as a continent. as we speak, there are several sites on the continent that have the capacity and capabilities of producing vaccines like the pasteur institute in senegal. south africa, egypt, morocco and tunisia, they all have that capacity and know how to produce, but they need to be supported, both in terms of technology transfer, both in terms of ip waiver, and in terms of really appropriate partnerships to enable them to move quickly into the areas of vaccine manufacturing there. so we are notjust a continent that we do not have anything,